Literature DB >> 17325960

The care of a child with multiple trauma and severe anemia who was a Jehovah's Witness.

Luciana Andrea Digieri1, Ivan Pollastrini Pistelli, Cid Eduardo de Carvalho.   

Abstract

Jehovah's Witness followers do not accept blood derived transfusions and available methods for avoiding transfusion have been used with degrees of success, demonstrating that the probability of death after trauma in these patients may not be significantly different from religious groups. In this report, we describe the case of a child victim of a multiple trauma with severe anemia due to blood loss, whose family would not authorize blood transfusion because of their Jehovah's Witness faith. We discuss the current indications for restricting transfusion, as well as highlighting new tools that contribute to the success of minimizing blood loss, thus avoiding transfusion.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17325960     DOI: 10.1080/10245330600774942

Source DB:  PubMed          Journal:  Hematology        ISSN: 1024-5332            Impact factor:   2.269


  4 in total

Review 1.  Reflections on Cultural Preferences and Internal Medicine: The Case of Jehovah's Witnesses and the Changing Thresholds for Blood Transfusions.

Authors:  Iftach Sagy; Alan Jotkowitz; Leonid Barski
Journal:  J Relig Health       Date:  2017-04

Review 2.  Surgical management in treatment of Jehovah's witness in trauma surgery in Indian subcontinent.

Authors:  Renu Kumari
Journal:  J Emerg Trauma Shock       Date:  2014-07

3.  Recombinant Human Erythropoietin Therapy for a Jehovah's Witness Child With Severe Anemia due to Hemolytic-Uremic Syndrome.

Authors:  Da Eun Woo; Jae Min Lee; Yu Kyung Kim; Yong Hoon Park
Journal:  Korean J Pediatr       Date:  2016-02-29

4.  Potential Efficacy of Erythropoietin on Reducing the Risk of Mortality in Patients with Traumatic Brain Injury: A Systematic Review and Meta-Analysis.

Authors:  Chengli Liu; Changsheng Huang; Jie Xie; Hui Li; Michael Hong; Xuemei Chen; Junmin Wang; Jiarui Wang; Zhanfei Li; Jian Wang; Wei Wang
Journal:  Biomed Res Int       Date:  2020-10-29       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.